Kyorin Holdings Inc banner

Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 641 JPY -0.06% Market Closed
Market Cap: ¥94.3B

Gross Margin

45.3%
Current
Improving
by 1.2%
vs 3-y average of 44.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
45.3%
=
Gross Profit
¥60.4B
/
Revenue
¥133.3B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
45.3%
=
Gross Profit
¥60.4B
/
Revenue
¥133.3B

Peer Comparison

Country Company Market Cap Gross
Margin
JP
Kyorin Holdings Inc
TSE:4569
94.3B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
875.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
563.9B USD
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.5B GBP
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
CH
Novartis AG
SIX:NOVN
225.3B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
294.7B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
156.7B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121.1B USD
Loading...

Market Distribution

Higher than 74% of companies in Japan
Percentile
74rd
Based on 6 625 companies
74rd percentile
45.3%
Low
-179.8% — 21.8%
Typical Range
21.8% — 42.3%
High
42.3% — 18 197.9%
Distribution Statistics
Japan
Min -179.8%
30th Percentile 21.8%
Median 30.6%
70th Percentile 42.3%
Max 18 197.9%

Kyorin Holdings Inc
Glance View

Market Cap
94.3B JPY
Industry
Pharmaceuticals

KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.

Kyorin Holdings Inc Intrinsic Value
LOCKED
Unlock
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
45.3%
=
Gross Profit
¥60.4B
/
Revenue
¥133.3B
What is Kyorin Holdings Inc's current Gross Margin?

The current Gross Margin for Kyorin Holdings Inc is 45.3%, which is above its 3-year median of 44.1%.

How has Gross Margin changed over time?

Over the last 3 years, Kyorin Holdings Inc’s Gross Margin has decreased from 46.3% to 45.3%. During this period, it reached a low of 42.6% on Dec 31, 2024 and a high of 46.3% on Dec 31, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett